STAAR Surgical Company (STAA) SEC Filings & Earnings Calls

Tariff impact on China gross margin

“Gross margin will continue to be impacted by tariffs until we can supply 100% of EVO and EVO+ ICL lenses for China from Switzerland, which should happen by the end of 2026.” · word for word

ERP implementation operational risk

“As sales volumes grew, unforeseen operational challenges emerged that required extensive daily manual intervention from teams across the organization.” · word for word

Middle East geopolitical risk

“Sales in the Middle East decreased 58% compared to the same period of last year.” · word for word

High concentration in China (over 50% of revenue) exposes company to regulatory, geopolitical, and demand risks.

“China, representing over 50% of revenue” · word for word

Seasonal shift in China could lead to sequential decline in Q3 and Q4.

“third quarter volumes typically step down from our first half peak ... fourth quarter remains a seasonally softer period” · word for word

Key person risk due to CEO transition; performance-based equity may incentivize short-term stock price focus.

“CEO appointment with performance stock options tied to stock price hurdles of $50, $75, $100 per share.”

Tariff and geopolitical uncertainty could impact supply chain and costs.

“we continue to operate in a dynamic global environment shaped by tariffs, geopolitical uncertainty, and uneven macroeconomic conditions” · word for word

ERP system rollout may cause operational disruptions.

“we are in the midst of the rollout of our new Enterprise Resource Planning (ERP) system... disruptions to the business have been limited” · word for word

China concentration risk

“Net sales to our two distributors in China were $47.4 million for the three months ended April 3, 2026, compared to net returns of $0.9 million in the prior-year period.” · word for word

Merger termination costs

“Merger transaction and related costs $6,743”

Executive turnover and leadership instability

“Multiple C-suite departures in 2025-2026: CEO Farrell (Jan 2026), CEO Frinzi (Feb 2025), CFO Williams (Mar 2025), CLO Sisitsky (Feb 2026). Interim co-CEO structure in place.”

China market dependency and consumer weakness

“Macroeconomic conditions in China had a significant impact on our business in 2024, where weak consumer consumption contributed to reduced demand for ICL procedures.” · word for word

Failed merger creates uncertainty

“Given the Company's pending merger with Alcon, which was terminated in January 2026.” · word for word

PSU performance targets not met

“The Company assessed PSU performance as of the end of the fourth quarter ended January 2, 2026, and as of such date, the Company had not yet hit any of the targets for the PSUs.” · word for word

Geopolitical and macroeconomic challenges in Middle East, EMEA, and APAC regions could negatively affect sales.

“In the Middle East and some other parts of the EMEA and APAC regions, net sales were negatively affected by significant geopolitical and macroeconomic challenges, resulting in a decline in sales in parts of those regions.” · word for word

No forward revenue or earnings guidance provided; business conditions remain volatile.

“Current global business conditions are volatile and some portions of our business remain unpredictable. We continue to provide no forward revenue or earnings guidance.” · word for word

Large concentrated ownership may lead to future activist pressure or governance changes

“the Reporting Persons have been and may continue to be in contact with members of the Issuer's management, Board, other significant shareholders and others regarding alternatives that the Issuer could employ to create significant additional shareholder value over time.” · word for word

Large concentrated ownership may lead to future activist pressure or governance changes

“the Reporting Persons have been and may continue to be in contact with members of the Issuer's management, Board, other significant shareholders and others regarding alternatives that the Issuer could employ to create significant additional shareholder value over time.” · word for word

China Demand Slowdown

“We believe the sluggish economy and weak consumer consumption that contributed to fluctuating demand for ICL procedures in China in fiscal 2024 and 2025 will continue in fiscal 2026.” · word for word

U.S.-China Tariff Risk

“If maintained, the newly announced tariffs and the potential escalation of trade disputes could pose a significant risk to our business and would affect our revenue and cost of goods sold.” · word for word

High Employee Turnover

“our global overall turnover rate in fiscal year 2025 was approximately 32.2% (excluding temporary employees), which is higher than the overall turnover rate of approximately 19.7% in the medical device industry.” · word for word

Distributor Inventory Overhang

“As expected, our sales in China declined in 2025, due to elevated levels of inventory held at our China distributors at the end of December 27, 2024.” · word for word

China business uncertainty due to inventory returns and Alcon merger overhang; leadership transitions.

“China sub-distributors returned inventory due to Alcon merger uncertainty; interim co-CEOs appointed.”

Key legal officer departure may signal governance or compliance risk, though transition consulting mitigates immediate disruption.

“Termination without cause of Chief Legal Officer; severance and consulting arrangement in place.”

Activist involvement (Broadwood Capital) may lead to strategic changes or pressure.

“Neal Bradsher is Founder/President of Broadwood Capital, largest stockholder.”

CEO succession uncertainty could disrupt operations.

“Search Committee formed to identify CEO successor.”

Leadership instability and activist involvement create execution risk

“CEO departure and board overhaul following activist agreement”

Merger completion risk remains until final approvals and closing conditions are met.

“Preliminary voting results; merger still subject to other conditions.”

Deal termination risk realized; no termination fee but strategic uncertainty and potential litigation.

“Merger agreement terminated after shareholder vote failed; no termination fee payable.”

Merger completion risk; regulatory and shareholder approvals required.

“Amendment to Agreement and Plan of Merger; merger subject to closing conditions including regulatory approvals.”

Merger completion uncertainty due to repeated postponements.

“meeting postponed from Dec 3 to Dec 19, 2025”

China distributor inventory destocking risk; $80-85M inventory reduction by distributors.

“Distributors in China reduced their inventory by approximately $80 million to $85 million.” · word for word

China revenue concentration and destocking

“Net sales to our two distributors in China were $60.3 million for the nine months ended September 26, 2025, compared to net sales of $154.5 million for the nine months ended September 27, 2024.” · word for word

Tariff exposure on US-origin products to China

“In April 2025, in response to the announcement of tariffs by the United States on Chinese goods, China announced retaliatory tariffs on U.S.-origin goods.” · word for word

Merger execution risk

“The respective obligations of STAAR, Alcon and Merger Sub to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver of a number of conditions.” · word for word

Merger approval risk due to postponement.

“Special meeting postponed from November 6 to December 3, 2025.”